AMENDMENT TO THE JOINT FILING AGREEMENT, DATED AS OF OCTOBER 5, 2026
NewGenIvf Group Ltd
Exhibit 10
** **
AMENDMENT TO JOINT FILING AGREEMENT
** **
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of an amendment No.2 to the Statement on Schedule 13D, which Amendment No. 2 amends and supplements the Amendment No. 1 to the Statement on Schedule 13D filed with the Securities and Exchange Commission on June 8, 2026 (the “Amendment No.1”) (including any and all amendments thereto) with respect to the Class B ordinary shares, no par value, of NewGenIvf Group Limited, a British Virgin Islands company, and further agree that this amendment to the Joint Filing Agreement originally dated April 10, 2024 shall be included as an Exhibit to such joint filings.
…